Effects of semaglutide on clinical events in heart failure with preserved ejection fraction: a pooled, participant-level analysis of SELECT, FLOW, STEP-HFpEF and STEP-HFpEF DM trials

30 August 2024 (09:00 - 09:11)
Organised by: Logo
Congress Presentation Part of: Clinical trial updates on the GLP-1 receptor agonist, semaglutide Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology